Epizyme - 51 Year Dividend History | EPZM

Historical dividend payout and yield for Epizyme (EPZM) since 1971. The current TTM dividend payout for Epizyme (EPZM) as of May 27, 2022 is $0.00. The current dividend yield for Epizyme as of May 27, 2022 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.075B $0.037B
Epizyme is a development-stage biopharmaceutical company, focused on bringing novel epigenetic therapies for the treatment of cancer and other diseases to the market. The company's proprietary product platform is used to create small molecule inhibitors of a class of enzymes known as histone methyltransferases (HMTs). Epizyme's focus is on inhibiting oncogenic HMTs for the treatment of the underlying causes of associated cancers.
Stock Name Country Market Cap PE Ratio